Related references
Note: Only part of the references are listed.Ascorbic Acid in Cancer Treatment: Let the Phoenix Fly
Niraj Shenoy et al.
CANCER CELL (2018)
Drugs with anti-oxidant properties can interfere with cell viability measurements by assays that rely on the reducing property of viable cells
Niraj Shenoy et al.
LABORATORY INVESTIGATION (2017)
Upregulation of TET activity with ascorbic acid induces epigenetic modulation of lymphoma cells
N. Shenoy et al.
BLOOD CANCER JOURNAL (2017)
Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia Progression
Luisa Cimmino et al.
CELL (2017)
Sequential pathogenesis of metastatic VHL mutant clear cell renal cell carcinoma: putting it together with a translational perspective
N. Shenoy et al.
ANNALS OF ONCOLOGY (2016)
Global 5-Hydroxymethylcytosine Levels Are Profoundly Reduced in Multiple Genitourinary Malignancies
Enrico Munari et al.
PLOS ONE (2016)
Hypoxia-Mediated Increases in L-2-hydroxyglutarate Coordinate the Metabolic Response to Reductive Stress
William M. Oldham et al.
CELL METABOLISM (2015)
Loss of TET2 in hematopoietic cells leads to DNA hypermethylation of active enhancers and induction of leukemogenesis
Kasper D. Rasmussen et al.
GENES & DEVELOPMENT (2015)
Role of DNA methylation in renal cell carcinoma
Niraj Shenoy et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)
Characterization of acute myeloid leukemia based on levels of global hydroxymethylation
Leonie I. Kroeze et al.
BLOOD (2014)
Kidney Cancer Is Characterized by Aberrant Methylation of Tissue-Specific Enhancers That Are Prognostic for Overall Survival
Caroline Y. Hu et al.
CLINICAL CANCER RESEARCH (2014)
Pharmacokinetic modeling of ascorbate diffusion through normal and tumor tissue
Caroline Kuiper et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
Randomized Comparison of Gemcitabine, Dexamethasone, and Cisplatin Versus Dexamethasone, Cytarabine, and Cisplatin Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed and Refractory Aggressive Lymphomas: NCIC-CTG LY.12
Michael Crump et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
High-Dose Parenteral Ascorbate Enhanced Chemosensitivity of Ovarian Cancer and Reduced Toxicity of Chemotherapy
Yan Ma et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
L-2-Hydroxyglutarate: An Epigenetic Modifier and Putative Oncometabolite in Renal Cancer
Eun-Hee Shim et al.
CANCER DISCOVERY (2014)
Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer
Christopher M. Stephenson et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Ascorbic Acid Enhances Tet-Mediated 5-Methylcytosine Oxidation and Promotes DNA Demethylation in Mammals
Ruichuan Yin et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)
Comprehensivemolecular characterization of clear cell renal cell carcinoma
Chad J. Creighton et al.
NATURE (2013)
Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells
Kathryn Blaschke et al.
NATURE (2013)
Genome-wide hydroxymethylation tested using the HELP-GT assay shows redistribution in cancer
Sanchari Bhattacharyya et al.
NUCLEIC ACIDS RESEARCH (2013)
TET2 Mutations in Acute Myeloid Leukemia (AML): Results From a Comprehensive Genetic and Clinical Analysis of the AML Study Group
Verena I. Gaidzik et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Phase I Evaluation of Intravenous Ascorbic Acid in Combination with Gemcitabine and Erlotinib in Patients with Metastatic Pancreatic Cancer
Daniel A. Monti et al.
PLOS ONE (2012)
Quantitative Sequencing of 5-Methylcytosine and 5-Hydroxymethylcytosine at Single-Base Resolution
Michael J. Booth et al.
SCIENCE (2012)
Angiogenic ability of metastatic squamous carcinoma in the cervical lymph nodes from unknown primary tumours
Beamon Agarwal et al.
JOURNAL OF CLINICAL PATHOLOGY (2011)
Isocitrate Dehydrogenase 1/2 Mutational Analyses and 2-Hydroxyglutarate Measurements in Wilms Tumors
Dinesh Rakheja et al.
PEDIATRIC BLOOD & CANCER (2011)
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
Maria E. Figueroa et al.
CANCER CELL (2010)
Wilms Tumor in a Child with L-2-hydroxyglutaric Aciduria
Robert E. Rogers et al.
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY (2010)
IDH mutations in glioma and acute myeloid leukemia
Lenny Dang et al.
TRENDS IN MOLECULAR MEDICINE (2010)
Optimized design and data analysis of tag-based cytosine methylation assays
Masako Suzuki et al.
GENOME BIOLOGY (2010)
Pharmacologic concentrations of ascorbate are achieved by parenteral administration and exhibit antitumoral effects
Julien Verrax et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
Mutation in TET2 in Myeloid Cancers
Francois Delhommeau et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Phase I clinical trial of i.v. ascorbic acid in advanced malignancy
L. J. Hoffer et al.
ANNALS OF ONCOLOGY (2008)
Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice
Qi Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo
Qi Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a pro-drug to deliver hydrogen peroxide to tissues
Q Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma - A stratification tool for prospective clinical trials
BC Leibovich et al.
CANCER (2003)
An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: The SSIGN score
I Frank et al.
JOURNAL OF UROLOGY (2002)
Share Paper
